<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 29 Sep 2026 07:29:10 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$31 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$31.00  (from R$29.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</guid>
   <pubDate>Tue, 29 Sep 2026 07:29:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$31 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$31.00  (from R$29.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</guid>
   <pubDate>Tue, 29 Sep 2026 07:29:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$31 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$31.00  (from R$29.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</guid>
   <pubDate>Tue, 29 Sep 2026 07:29:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$31 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$31.00  (from R$29.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2431+at+JPMorgan/27117379.html</guid>
   <pubDate>Tue, 29 Sep 2026 07:29:10 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$32.50 at Morgan Stanley</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</link>
   <description>Morgan Stanley analyst Mauricio I Cepeda raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$32.50  (from R$31.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</guid>
   <pubDate>Thu, 24 Sep 2026 05:27:07 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$32.50 at Morgan Stanley</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</link>
   <description>Morgan Stanley analyst Mauricio I Cepeda raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$32.50  (from R$31.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</guid>
   <pubDate>Thu, 24 Sep 2026 05:27:07 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$32.50 at Morgan Stanley</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</link>
   <description>Morgan Stanley analyst Mauricio I Cepeda raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$32.50  (from R$31.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</guid>
   <pubDate>Thu, 24 Sep 2026 05:27:07 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$32.50 at Morgan Stanley</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</link>
   <description>Morgan Stanley analyst Mauricio I Cepeda raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$32.50  (from R$31.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2432.50+at+Morgan+Stanley/27098173.html</guid>
   <pubDate>Thu, 24 Sep 2026 05:27:07 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>UBS Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</link>
   <description>&lt;p&gt;UBS analyst Vinicius Strano upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade HYPE from Neutral to Buy, with a price target of R$28/share. With the working capital reset complete, we believe the company is well positioned to sustain solid sell-out growth while entering a positive ROIC inflection, supporting a potential re-rating ahead. GLP-1 optionality is approaching, with a planned Semaglutide launch in 3Q26 tapping a ~R$5.2bn LTM TAM in 2026. Beyond GLP-1, HYPE is positioned to benefit from a broader set of patent cliffs and recent launches, representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</guid>
   <pubDate>Wed, 03 Jun 2026 02:27:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>UBS Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Upgrades/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</link>
   <description>&lt;p&gt;UBS analyst Vinicius Strano upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade HYPE from Neutral to Buy, with a price target of R$28/share. With the working capital reset complete, we believe the company is well positioned to sustain solid sell-out growth while entering a positive ROIC inflection, supporting a potential re-rating ahead. GLP-1 optionality is approaching, with a planned Semaglutide launch in 3Q26 tapping a ~R$5.2bn LTM TAM in 2026. Beyond GLP-1, HYPE is positioned to benefit from a broader set of patent cliffs and recent launches, representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</guid>
   <pubDate>Wed, 03 Jun 2026 02:27:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>UBS Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</link>
   <description>&lt;p&gt;UBS analyst Vinicius Strano upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade HYPE from Neutral to Buy, with a price target of R$28/share. With the working capital reset complete, we believe the company is well positioned to sustain solid sell-out growth while entering a positive ROIC inflection, supporting a potential re-rating ahead. GLP-1 optionality is approaching, with a planned Semaglutide launch in 3Q26 tapping a ~R$5.2bn LTM TAM in 2026. Beyond GLP-1, HYPE is positioned to benefit from a broader set of patent cliffs and recent launches, representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</guid>
   <pubDate>Wed, 03 Jun 2026 02:27:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>UBS Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</link>
   <description>&lt;p&gt;UBS analyst Vinicius Strano upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade HYPE from Neutral to Buy, with a price target of R$28/share. With the working capital reset complete, we believe the company is well positioned to sustain solid sell-out growth while entering a positive ROIC inflection, supporting a potential re-rating ahead. GLP-1 optionality is approaching, with a planned Semaglutide launch in 3Q26 tapping a ~R$5.2bn LTM TAM in 2026. Beyond GLP-1, HYPE is positioned to benefit from a broader set of patent cliffs and recent launches, representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</guid>
   <pubDate>Wed, 03 Jun 2026 02:27:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>UBS Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Upgrades/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</link>
   <description>&lt;p&gt;UBS analyst Vinicius Strano upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade HYPE from Neutral to Buy, with a price target of R$28/share. With the working capital reset complete, we believe the company is well positioned to sustain solid sell-out growth while entering a positive ROIC inflection, supporting a potential re-rating ahead. GLP-1 optionality is approaching, with a planned Semaglutide launch in 3Q26 tapping a ~R$5.2bn LTM TAM in 2026. Beyond GLP-1, HYPE is positioned to benefit from a broader set of patent cliffs and recent launches, representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</guid>
   <pubDate>Wed, 03 Jun 2026 02:27:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>UBS Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</link>
   <description>&lt;p&gt;UBS analyst Vinicius Strano upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00.&lt;/p&gt;&lt;p&gt;The analyst comments: “We upgrade HYPE from Neutral to Buy, with a price target of R$28/share. With the working capital reset complete, we believe the company is well positioned to sustain solid sell-out growth while entering a positive ROIC inflection, supporting a potential re-rating ahead. GLP-1 optionality is approaching, with a planned Semaglutide launch in 3Q26 tapping a ~R$5.2bn LTM TAM in 2026. Beyond GLP-1, HYPE is positioned to benefit from a broader set of patent cliffs and recent launches, representing</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26594260.html</guid>
   <pubDate>Wed, 03 Jun 2026 02:27:45 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Citi Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</link>
   <description>&lt;p&gt;Citi analyst Leandro Bastos upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00 (from R$26.00).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</guid>
   <pubDate>Thu, 14 May 2026 05:28:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Citi Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Upgrades/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</link>
   <description>&lt;p&gt;Citi analyst Leandro Bastos upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00 (from R$26.00).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</guid>
   <pubDate>Thu, 14 May 2026 05:28:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Citi Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</link>
   <description>&lt;p&gt;Citi analyst Leandro Bastos upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00 (from R$26.00).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</guid>
   <pubDate>Thu, 14 May 2026 05:28:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Citi Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</link>
   <description>&lt;p&gt;Citi analyst Leandro Bastos upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00 (from R$26.00).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</guid>
   <pubDate>Thu, 14 May 2026 05:28:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Citi Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Upgrades/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</link>
   <description>&lt;p&gt;Citi analyst Leandro Bastos upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00 (from R$26.00).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Upgrades/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</guid>
   <pubDate>Thu, 14 May 2026 05:28:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Citi Upgrades Hypera SA (HYPE3:BZ) (HYPMY) to Buy</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</link>
   <description>&lt;p&gt;Citi analyst Leandro Bastos upgraded Hypera SA (HYPE3:BZ) (OTC: HYPMY) from Neutral to Buy with a price target of R$28.00 (from R$26.00).&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Citi+Upgrades+Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+to+Buy/26488690.html</guid>
   <pubDate>Thu, 14 May 2026 05:28:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$33 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$33.00  (from R$32.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</guid>
   <pubDate>Wed, 04 Feb 2026 09:00:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$33 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$33.00  (from R$32.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</guid>
   <pubDate>Wed, 04 Feb 2026 09:00:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$33 at JPMorgan</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$33.00  (from R$32.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</guid>
   <pubDate>Wed, 04 Feb 2026 09:00:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Raised to R$33 at JPMorgan</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</link>
   <description>JPMorgan analyst Joseph Giordano raised the price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$33.00  (from R$32.00) while maintaining a Overweight rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Raised+to+R%2433+at+JPMorgan/25943984.html</guid>
   <pubDate>Wed, 04 Feb 2026 09:00:12 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
  <item>
   <title>Hypera SA (HYPE3:BZ) (HYPMY) PT Lowered to R$28 at UBS</title>
   <link>http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Lowered+to+R%2428+at+UBS/25884799.html</link>
   <description>UBS lowered its price target on Hypera SA (HYPE3:BZ) (OTC: HYPMY) to R$28.00  (from R$29.00) while maintaining a Neutral rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Intl+Ratings/Hypera+SA+%28HYPE3%3ABZ%29+%28HYPMY%29+PT+Lowered+to+R%2428+at+UBS/25884799.html</guid>
   <pubDate>Fri, 23 Jan 2026 09:23:46 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">HYPMY</category>
   	  </item>
 </channel>
</rss>
